Interestingly, anti-PD-L1+ NP3 treatment decreased the CD163 expression of M2-TAMs and significantly increase the expression of anti-tumour M1 macrophages and cytotoxic CD8 lymphocytes. The gene discussed is CD8A; the disease is neoplasm.